Cross-trial comparisons in reviews: proceed with caution
- PMID: 32807928
- DOI: 10.1038/s41584-020-0492-3
Cross-trial comparisons in reviews: proceed with caution
References
- 
    - Gasparyan, A. Y., Ayvazyan, L., Blackmore, H. & Kitas, G. D. Writing a narrative biomedical review: considerations for authors, peer reviewers and editors. Rheumatol. Int. 31, 1409–1417 (2011). - DOI
 
- 
    - Naylor, C. D. Grey zones of clinical practice: some limits to evidence-based medicine. Lancet 345, 840–842 (1995). - DOI
 
- 
    - Chang, S. & Lee, T. H. Beyond evidence-based medicine. N. Engl. J. Med. 379, 1983–1985 (2018). - DOI
 
- 
    - Lee, C. K. et al. Historical cross-trial comparisons for competing treatments in advanced breast cancer-an empirical analysis of bias. Eur. J. Cancer 46, 541–548 (2010). - DOI
 
- 
    - Bergeris, A., Tse, T. & Zarin, D. A. Trialists’ intent to share individual participant data as disclosed at ClinicalTrials.gov. JAMA 319, 406–408 (2018). - DOI
 
MeSH terms
LinkOut - more resources
- Full Text Sources
- Medical
 
        